MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2026.2724623

Медицинская библиотека · The Journal of dermatological treatment · 2026

Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.

Fatani Mohammed Ibrahim, Binamer Yousef, Alessa Dana, Almudaiheem Hajer Y, Alajlan Mohammed Abdulaziz, Hamadah Issam, Al-Omari Bedor A, Alzuriqan Fahad, Alotaibi Haifa F, Alhazzani Waleed, Aljedai Ahmed, Eshmawi Maysa Tariq

СтатьяКлинические рекомендацииСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Psoriasis is a chronic, immune-mediated inflammatory skin disease that affects approximately 5.3% of the population in the Kingdom of Saudi Arabia (KSA). Thus, we aim to develop updated evidence-based clinical practice guidelines for the management of adults and pediatric patients with moderate-to-severe plaque psoriasis in the KSA.

METHODS

These guidelines followed the "Grading of Recommendations, Assessment, Development, and Evaluation" (GRADE) methodology. We conducted a systematic literature review of PubMed, EMBASE, and the Cochrane Library for high-quality evidence published between 2020 and 2026. The panel developed 31 PICO questions that address key treatment considerations for moderate-to-severe psoriasis.

RESULTS

We established 27 evidence-based recommendations and 4 good-practice statements addressing key aspects of moderate-to-severe psoriasis management. These guidelines strongly recommend adopting the Psoriasis Area and Severity Index (PASI) 90 as the primary treatment goal over PASI 75. For adult patients, the guidelines recommend biologic therapies, including interleukin (IL)-17 inhibitors, IL-23 inhibitors, IL-12/23 inhibitors, and tumor necrosis factor (TNF)-α inhibitors, for better disease control. For pediatric patients, the guidelines recommend early initiation of biologic therapy, with etanercept, secukinumab, ixekizumab, and adalimumab as preferred options.

CONCLUSION

These Saudi national guidelines offer a comprehensive, evidence-based framework for managing moderate-to-severe psoriasis in adults and pediatric patients.

Для цитирования: Fatani Mohammed Ibrahim, Binamer Yousef, Alessa Dana, Almudaiheem Hajer Y, Alajlan Mohammed Abdulaziz, Hamadah Issam, Al-Omari Bedor A, Alzuriqan Fahad, Alotaibi Haifa F, Alhazzani Waleed, Aljedai Ahmed, Eshmawi Maysa Tariq. Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.. The Journal of dermatological treatment. 2026. DOI: 10.1080/09546634.2026.2724623.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.